We use cookies to improve your experience

We value your privacy and strive to enhance your experience. By continuing to browse our site, you agree to our use of cookies to offer you tailored content and seamless services. Learn more

IVD Contract Manufacturing Market Size, Share, and Trends 2024 to 2034

The global IVD contract manufacturing market size was USD 17.19 billion in 2023, calculated at USD 19.17 billion in 2024 and is projected to surpass around USD 56.94 billion by 2034, expanding at a CAGR of 11.5% from 2024 to 2034.

  • Last Updated : September 2024
  • Report Code : 3641
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on IVD Contract Manufacturing Market 

5.1. COVID-19 Landscape: IVD Contract Manufacturing Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global IVD Contract Manufacturing Market, By Device Type

8.1. IVD Contract Manufacturing Market, by Device Type, 2024-2034

8.1.1 IVD Equipment

8.1.1.1. Market Revenue and Forecast (2021-2034)

8.1.2. IVD Consumables

8.1.2.1. Market Revenue and Forecast (2021-2034)

Chapter 9. Global IVD Contract Manufacturing Market, By Technology

9.1. IVD Contract Manufacturing Market, by Technology, 2024-2034

9.1.1. Immunoassay

9.1.1.1. Market Revenue and Forecast (2021-2034)

9.1.2. Clinical Chemistry

9.1.2.1. Market Revenue and Forecast (2021-2034)

9.1.3. Molecular Diagnostics

9.1.3.1. Market Revenue and Forecast (2021-2034)

9.1.4. Microbiology

9.1.4.1. Market Revenue and Forecast (2021-2034)

9.1.5. Hematology

9.1.5.1. Market Revenue and Forecast (2021-2034)

9.1.6. Coagulation & Hemostasis

9.1.6.1. Market Revenue and Forecast (2021-2034)

9.1.7. Others

9.1.7.1. Market Revenue and Forecast (2021-2034)

Chapter 10. Global IVD Contract Manufacturing Market, By Service Type 

10.1. IVD Contract Manufacturing Market, by Service Type, 2024-2034

10.1.1. Manufacturing Services

10.1.1.1. Market Revenue and Forecast (2021-2034)

10.1.2. Assay Development Services

10.1.2.1. Market Revenue and Forecast (2021-2034)

10.1.3. Other Services

10.1.3.1. Market Revenue and Forecast (2021-2034)

Chapter 11. Global IVD Contract Manufacturing Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Device Type (2021-2034)

11.1.2. Market Revenue and Forecast, by Technology (2021-2034)

11.1.3. Market Revenue and Forecast, by Service Type (2021-2034)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Device Type (2021-2034)

11.1.4.2. Market Revenue and Forecast, by Technology (2021-2034)

11.1.4.3. Market Revenue and Forecast, by Service Type (2021-2034)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Device Type (2021-2034)

11.1.5.2. Market Revenue and Forecast, by Technology (2021-2034)

11.1.5.3. Market Revenue and Forecast, by Service Type (2021-2034)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Device Type (2021-2034)

11.2.2. Market Revenue and Forecast, by Technology (2021-2034)

11.2.3. Market Revenue and Forecast, by Service Type (2021-2034)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Device Type (2021-2034)

11.2.4.2. Market Revenue and Forecast, by Technology (2021-2034)

11.2.4.3. Market Revenue and Forecast, by Service Type (2021-2034)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Device Type (2021-2034)

11.2.5.2. Market Revenue and Forecast, by Technology (2021-2034)

11.2.5.3. Market Revenue and Forecast, by Service Type (2021-2034)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Device Type (2021-2034)

11.2.6.2. Market Revenue and Forecast, by Technology (2021-2034)

11.2.6.3. Market Revenue and Forecast, by Service Type (2021-2034)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Device Type (2021-2034)

11.2.7.2. Market Revenue and Forecast, by Technology (2021-2034)

11.2.7.3. Market Revenue and Forecast, by Service Type (2021-2034)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Device Type (2021-2034)

11.3.2. Market Revenue and Forecast, by Technology (2021-2034)

11.3.3. Market Revenue and Forecast, by Service Type (2021-2034)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Device Type (2021-2034)

11.3.4.2. Market Revenue and Forecast, by Technology (2021-2034)

11.3.4.3. Market Revenue and Forecast, by Service Type (2021-2034)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Device Type (2021-2034)

11.3.5.2. Market Revenue and Forecast, by Technology (2021-2034)

11.3.5.3. Market Revenue and Forecast, by Service Type (2021-2034)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Device Type (2021-2034)

11.3.6.2. Market Revenue and Forecast, by Technology (2021-2034)

11.3.6.3. Market Revenue and Forecast, by Service Type (2021-2034)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Device Type (2021-2034)

11.3.7.2. Market Revenue and Forecast, by Technology (2021-2034)

11.3.7.3. Market Revenue and Forecast, by Service Type (2021-2034)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Device Type (2021-2034)

11.4.2. Market Revenue and Forecast, by Technology (2021-2034)

11.4.3. Market Revenue and Forecast, by Service Type (2021-2034)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Device Type (2021-2034)

11.4.4.2. Market Revenue and Forecast, by Technology (2021-2034)

11.4.4.3. Market Revenue and Forecast, by Service Type (2021-2034)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Device Type (2021-2034)

11.4.5.2. Market Revenue and Forecast, by Technology (2021-2034)

11.4.5.3. Market Revenue and Forecast, by Service Type (2021-2034)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Device Type (2021-2034)

11.4.6.2. Market Revenue and Forecast, by Technology (2021-2034)

11.4.6.3. Market Revenue and Forecast, by Service Type (2021-2034)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Device Type (2021-2034)

11.4.7.2. Market Revenue and Forecast, by Technology (2021-2034)

11.4.7.3. Market Revenue and Forecast, by Service Type (2021-2034)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Device Type (2021-2034)

11.5.2. Market Revenue and Forecast, by Technology (2021-2034)

11.5.3. Market Revenue and Forecast, by Service Type (2021-2034)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Device Type (2021-2034)

11.5.4.2. Market Revenue and Forecast, by Technology (2021-2034)

11.5.4.3. Market Revenue and Forecast, by Service Type (2021-2034)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Device Type (2021-2034)

11.5.5.2. Market Revenue and Forecast, by Technology (2021-2034)

11.5.5.3. Market Revenue and Forecast, by Service Type (2021-2034)

Chapter 12. Company Profiles

12.1. Thermo Fisher Scientific Inc.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Siemens Healthineers AG

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Danaher Corporation

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Roche Diagnostics

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Ortho Clinical Diagnostics

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Abbott Laboratories

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Bio-Rad Laboratories, Inc.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Sysmex Corporation

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Quidel Corporation

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. BioMérieux SA

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global IVD contract manufacturing market size is expected to increase USD 56.94 billion by 2034 from USD 17.19 billion in 2023.

The global IVD contract manufacturing market will register growth rate of 11.5% between 2024 and 2034.

The major players operating in the IVD contract manufacturing market are Thermo Fisher Scientific Inc., Siemens Healthineers AG, Danaher Corporation, Roche Diagnostics, Ortho Clinical Diagnostics, Abbott Laboratories, Bio-Rad Laboratories, Inc., Sysmex Corporation, Quidel Corporation, BioMérieux SA, PerkinElmer Inc., DiaSorin S.p.A., Luminex Corporation, Becton, Dickinson and Company (BD), Meridian Bioscience, Inc., and Others.

The driving factors of the IVD contract manufacturing market are the outsourcing efficiency and technological convergence.

North America region will lead the global IVD contract manufacturing market during the forecast period 2024 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client